Sierra Oncology (SRRA) Halted on Volatility, Up 64%
- Wall Street ends mixed after punishing week
- '3600 is the New Bull Case': Outflows from Energy and Materials Highest in Several Years - BofA
- Dollar catches a break after bruising week as investors turn risk averse
- Apple (AAPL) is a 'Compelling Name To Own' Right Now, iPhone Sales Trending Ahead of Guidance - Wedbush's Ives
- Deere (DE) Falls on Sales Miss, JPMorgan Sees 'Aggressive' Guidance and Downside Risk
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Sierra Oncology (NASDAQ: SRRA) Halted on Volatility, Up 64%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Decisionpoint Systems (DPSI) Halted on Volatility
- Foghorn Therapeutics (FHTX) Phase 1 Study of FHD-286 Placed on Partial Clinical Hold
- Plug Power (PLUG) Bucks Market Weakness Amid Electrolyzer Order
Create E-mail Alert Related CategoriesMomentum Movers, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!